Clinical implications of the insulin resistance syndrome (Q33842437)

29 July 2017

1 reference

title

Clinical implications of the insulin resistance syndrome (English)

1 reference

29 July 2017

1 reference

1 reference

W T Garvey

1

1 reference

29 July 2017

K L Hermayer

series ordinal

2

1 reference

29 July 2017

publication date

1 January 1998

1 reference

29 July 2017

1 reference

29 July 2017

volume

1

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

13-28

1 reference

Banting lecture 1988. Role of insulin resistance in human disease

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2898%2990015-1

7 January 2021

Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2898%2990015-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1098-3597%2898%2990015-1

1 reference

7 January 2021

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2898%2990015-1

7 January 2021

Troglitazone Improves Defects in Insulin Action, Insulin Secretion, Ovarian Steroidogenesis, and Fibrinolysis in Women with Polycystic Ovary Syndrome1

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2898%2990015-1

7 January 2021

Consensus Development Conference on Insulin Resistance. 5-6 November 1997. American Diabetes Association

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2898%2990015-1

7 January 2021

Non-insulin-dependent diabetes mellitus--a collision between thrifty genes and an affluent society

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2898%2990015-1

7 January 2021

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2898%2990015-1

7 January 2021

Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance. The Framingham Offspring Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2898%2990015-1

7 January 2021

Relation of body fat distribution to metabolic complications of obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2898%2990015-1

7 January 2021

Insulin Resistance in Secondary Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2898%2990015-1

7 January 2021

Influence of body fat distribution on free fatty acid metabolism in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2898%2990015-1

7 January 2021

Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2898%2990015-1

7 January 2021

Some coronary risk factors related to the insulin resistance syndrome and treatment with gemfibrozil. Experience from the Helsinki Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2898%2990015-1

7 January 2021

Aspirin therapy in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2898%2990015-1

7 January 2021

Homocysteine and atherothrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2898%2990015-1

7 January 2021

10.1016/S1098-3597(98)90015-1

Identifiers

DOI

1 reference

29 July 2017

1 reference